3-(aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB.
By Kong T. Nguyen, E. Luethi, S. Syed, S. Urwyler, Sonia Bertrand, Daniel Bertrand, Jean-Louis Reymond. 2009
21 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Molecular Biology, Spectroscopy
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Jean-Louis Reymond
- Ruud Van Deursen
- Lorenz C. Blum
- Lars Ruddigkeit
- Fabian López-Vallejo
- Karina Martínez-Mayorga
- José L. Medina-Franco
- Marc A. Giulianotti
In Molecular Biology
- Jean-Louis Reymond
- Ruud Van Deursen
- Lorenz C. Blum
- Lars Ruddigkeit
- Fabian López-Vallejo
- Karina Martínez-Mayorga
- José L. Medina-Franco
- Marc A. Giulianotti
In Spectroscopy
Citations in the corpus
- The enumeration of chemical space (2012, background): “We have reported ligand discovery examples for inhibitors of the NMDA glycine site, 138 , 139 the nicotinic acetylcholine receptor, 140 , 141 and the glutamate transporter GLT-1.”
- Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. (2011, methodology): “GDB has been used successfully in VS coupled with chemical synthesis and biological testing [39, 40].”
- Visualisation and subsets of the chemical universe database GDB-13 for virtual screening (2011, background): “4 million virtual molecules up to 11 non-hydrogen atoms of C, N, O, F [12, 13], which was shown to provide a useful starting point for designing bioactive synthetic ligands [14–17].”